Cargando…
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain
The aim of the study was to assess the budgetary impact of funding smoking-cessation drugs in COPD patients in Spain. A hybrid model (cohort and Markov) was developed for a 5-year time horizon. Only approved cessation drugs (varenicline, bupropion, and nicotine replacement therapy) were considered....
Autores principales: | Jiménez-Ruiz, Carlos A, Solano-Reina, Segismundo, Signes-Costa, Jaime, de Higes-Martinez, Eva, Granda-Orive, José I, Lorza-Blasco, José J, Riesco-Miranda, Juan A, Altet-Gomez, Neus, Barrueco, Miguel, Oyagüez, Itziar, Rejas, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590338/ https://www.ncbi.nlm.nih.gov/pubmed/26451100 http://dx.doi.org/10.2147/COPD.S87597 |
Ejemplares similares
-
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012) -
Documento de posicionamiento de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) ante las estrategias de reducción del daño del tabaco
por: Jiménez Ruiz, Carlos A., et al.
Publicado: (2022) -
Certified Smoking Cessation Units in Spain: High Potential for Detection of Undiagnosed Chronic Obstructive Pulmonary Disease and Profile of Newly Diagnosed Cases
por: Riesco-Miranda, Juan-Antonio, et al.
Publicado: (2021) -
Factors associated with smoking among tuberculosis patients in Spain
por: Jiménez-Fuentes, María Ángeles, et al.
Publicado: (2016) -
Intervenciones en tabaquismo en pacientes con enfermedades cardiovasculares
por: de Granda-Orive, José Ignacio, et al.
Publicado: (2013)